Register for a Zenrelia™ discovery session

Zenrelia™ contains ilunocitinib. Legal category POM-V in UK.

Further information can be found in the Summary of Product Characteristics. Use medicines responsibly (UK):  APHA, NOAH. Advice should be sought from the prescriber prior to use. Prescription decisions are for the person issuing the prescription alone.

Zenrelia™, Elanco™ and the diagonal bar logo are trademarks of Elanco or its affiliates.

Apoquel^® is a trademark of Zoetis UK Limited & Zoetis Belgium (IE).

For product related technical queries, contact the Elanco Vets team:

Telephone: 01256 353131, selecting option 1 for technical services

Email: ElancoVets@elanco.com*

*please note this inbox will be checked during the next business day. If you require an urgent response to a product-use query, suspected adverse event or quality complaint regarding an Elanco product, please call 01256 353131 choosing option 1 for technical services. Outside of office hours, your call will be forwarded to our medical answer service and an Elanco representative will call you back. Thank you for your understanding.

Zenrelia is available in the following pack sizes:

4.8 mg: x30 or x90 tablets Product Information GB Product Information NI

6.4 mg: x30 or x90 tablets Product Information GB Product Information NI

8.5 mg: x30 or x90 tablets Product Information GB Product Information NI

15 mg: x30 or x90 tablets Product Information GB Product Information NI

Package leaflet GB 

Package leaflet NI

Why is there separate information for Northern Ireland?

Following the UK’s exit from the European Union, under the terms of the UK/EU Trade and Co-operation Agreement, EU law, including laws regulating veterinary medicines, are required to be applied in Northern Ireland (NI). Where products like Zenrelia, are authorised in both Great Britain (GB) and NI, the Summary of Product Characteristics can be different as the products are being authorised under different regulatory regimes (VMD in GB, EMA in NI).